PreprintAll rights reservedmedRxiv
Serum Raman spectroscopy as a blood-based triage test for bladder cancer: a retrospective proof-of-concept study
- 1Serox Ltd
Related
- Machine learning-assisted serum Raman spectroscopy for risk stratification in men with suspected prostate cancer: a retrospective proof-of-concept study
- NEITHER study: NICE versus EAU inconsistent triage, expenses and reliability in non–high‐risk non‐muscle invasive bladder cancer surveillance
- Cxbladder Triage in Haematuria Assessment Reduces Time From Referral to Specialist Assessment and Bladder Cancer Treatment and Improves Equity for Māori
- Cytoreductive cystectomy combined with chemotherapy versus chemotherapy alone in the treatment of metastatic bladder cancer: A retrospective comparative study.
- Guidewire-assisted en bloc resection of periorifice non-muscle-invasive bladder cancer: a retrospective case series.
BibTeX
@misc{milligan2026serum,
title = {{Serum Raman spectroscopy as a blood-based triage test for bladder cancer: a retrospective proof-of-concept study}},
author = {K. Milligan and I. Smith and A. Flugge and N. Fakhrua Aldeen and B. Shine and C. Muldoon},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.26.26366501},
url = {https://www.medrxiv.org/content/10.64898/2026.10.26.26366501v1},
}
RIS
TY - UNPB
TI - Serum Raman spectroscopy as a blood-based triage test for bladder cancer: a retrospective proof-of-concept study
AU - K. Milligan
AU - I. Smith
AU - A. Flugge
AU - N. Fakhrua Aldeen
AU - B. Shine
AU - C. Muldoon
PY - 2026
DA - 2026/10/26
PB - medRxiv
DO - 10.64898/2026.10.26.26366501
UR - https://www.medrxiv.org/content/10.64898/2026.10.26.26366501v1
ER -